טוען...
Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?
BACKGROUND: Suppressive doses of levothyroxine therapy are reported to reduce bone mineral density (BMD) in women. Data on bone changes in premenopausal hypothyroid women with replacement therapy are limited. Hence, this study was undertaken to evaluate bone changes in this group using bone markers...
שמור ב:
| הוצא לאור ב: | Clin Med Insights Womens Health |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Libertas Academica
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362625/ https://ncbi.nlm.nih.gov/pubmed/25861238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMWH.S22114 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|